A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of Standard And New Antiepileptic Drugs
Not Applicable
Completed
- Conditions
- EpilepsyNervous System Diseases
- Registration Number
- ISRCTN38354748
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
2007 valproate trial results in http://www.ncbi.nlm.nih.gov/pubmed/17382828 2007 carbamazepine trial results in http://www.ncbi.nlm.nih.gov/pubmed/17382827 2007 HTA monograph in http://www.ncbi.nlm.nih.gov/pubmed/17903391 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25630353 2019 results in https://pubmed.ncbi.nlm.nih.gov/30900756/
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2437
Inclusion Criteria
Patients recently suffering seizures
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes will be retention time on randomised drug and time to one year remission of seizures.
- Secondary Outcome Measures
Name Time Method Secondary outcomes will include psychosocial measures and impact on direct medical costs.